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Abstract
Background: The Youden index, the sum of sensitivity and specificity minus one, is an index used for setting
optimal thresholds on medical tests.
Discussion: When using this index, one implicitly uses decision theory with a ratio of misclassification costs which
is equal to one minus the prevalence proportion of the disease. It is doubtful whether this cost ratio truly
represents the decision maker’s preferences. Moreover, in populations with a different prevalence, a selected
threshold is optimal with reference to a different cost ratio.
Summary: The Youden index is not a truly optimal decision rule for setting thresholds because its cost ratio varies
with prevalence. Researchers should look into their cost ratio and employ it in a decision theoretic framework to
obtain genuinely optimal thresholds.
Background
In the clinical field there is a need for obtaining optimal
cut offs on markers or tests for separating persons with
a specific condition (diseased) from those without this
condition (healthy). The quality of a clinical test with
threshold c is often expressed in a table such as Addi-
tional file 1: Table S1.
In this table, D is the diagnosis; a person is either dis-
eased (D+) or healthy (D-). The prevalence P is the pro-
portion of persons diseased. T is the test result; c is a
cut-off point on the test. Persons with test scores larger
than or equal to c are tested positive and persons scor-
ing below c are tested negative. Unfortunately, one is
commonly faced with an imperfect relation between
diagnosis and test result, and therefore there are four
possible outcomes: false positives, true negatives, true
positives, and false negatives. The abbreviations (FPc,
TNc,T P c,a n dF N c) in Additional file 1: Table S1 repre-
sent the proportion of the population in each cell.
When c changes, these proportions, and the level of the
test Qc change as well. The quality of a medical test is
often expressed in terms of the two conditional prob-
abilities describing its performance with reference to the
diagnosis. Sensitivity (SE) is the probability that a dis-
eased person is tested as such (see, bottom of the table).
Specificity (SP) is the probability that a healthy person
has a negative test outcome. In general, SE and SP are
inversely related and vary with the threshold: when
using a higher (lower) value for c,S E c will decrease
(increase) and SPc will increase (decrease).
An index for setting thresholds on tests is the Youden
index [1], which is defined as
Jcc c =+− SE SP 1. (1)
The index is calculated for each threshold c,a n dt h e
value c*, which achieves a maximum, is referred to as
the ‘optimal’ threshold.
In the original article by Youden it was stated that the
index “assumes false positives to be as undesirable as
false negatives” ([1], p. 33), and that it “is independent
of the relative sizes of the control and diseased groups”
(Feature 5, p. 33). Although the paper was criticized at
first [2], the index gained some popularity with clinical
researchers (especially in psychiatry, see, e.g., [3]) and
statisticians. Recently, for example, it was said to be the
index which is “easiest to apply and does not require
further information such as prevalence rates and deci-
sion error costs” ([4], p. 459), and that other indices are
“influenced by the disease prevalence”, whereas You-
den’s J is not ([5], par. 1.2.3).
All this seems to suggest that when using the index, i)
incorrect classifications of healthy and diseased persons
are equally costly, and ii) that prevalence does not play a
role. As we will see, the former is only true in one specific
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any medium, provided the original work is properly cited.situation. Moreover, the index is optimal with respect to
misclassification costs which are related to the prevalence.
Discussion
When determining optimal thresholds in a decision the-
oretic approach, an obvious first step is to calculate
Expected Costs (EC) for each threshold, which can be
directly obtained by multiplying the costs (C) of erro-
neous decisions and benefits (B) of correct decisions by
their matching proportions and adding the four pro-
ducts (see, Additional file 1: Table S1):
EC FP FN
TN TP
cF PcF N c
TN c TP c
CC
BB
=× +×
−× −× .
(2)
The threshold with the lowest EC is the optimal thresh-
old c*. Instead of looking at the benefits or costs of each
of the four outcomes, it is often more convenient to con-
sider the following ratio of costs (see, e.g., [6], p. 119):
r
BTP CFN
BTP BTN CFN CFP
=
−
+−−
, (3)
where BTP − CFN reflects how much difference in costs
it makes whether diseased persons are classified correctly
or not, and BTN − CFP reflects how much difference it
makes whether healthy persons are classified correctly or
not. The value of r will be close to one if the difference in
costs between correct and incorrect classifications is
much larger for diseased persons; if it is close to zero
then this difference is much larger for healthy persons.
Only when r is close to 0.5, the difference in costs is
about equal for healthy and diseased persons. EC is often
rewritten in terms of r and rescaled to improve its useful-
ness. For example, when rewriting Equation 2, and
removing some constants [[7], Equation 3] we get EC’:
EC SE SP ′ =× × + − () ×× − () cc c Pr P r 11 (4)
=× + + − () TP TN cc rr 1. (5)
EC and EC’ give identical c*.
1 For linking Youden’s J
to it, a further elaboration on the decision theoretic
approach is not necessary. Kraemer ([6], pp. 121-123)
showed, however, how EC, like SE and SP, is an uncali-
brated measure in the sense that it depends on the level
of the test and prevalence. She rescaled EC into index
(r), which may be written as:
 r
rP Q r P Q c
cc cc
cc
()=
×− ×
×× − () +− () ×− () ×
TN TP FN FP
11 1
. (6)
The index (r) is a weighted kappa coefficient [8]
between test and diagnosis, and should range in value
between zero and one. The optimal cut-off c* for a par-
ticular value of r is the one with the highest value of
(r); EC and (r) do not necessarily give identical c*.
It is now informative to rewrite Equation 1. Given that
subtracting a constant does not change the choice for c*,
′ =+
− ()
J c
P
c
P
c
TP TN
1
. (7)
This can be reduced to:
′ =
×− () +×
×− ()
J c P c P
PP
c
TP TN 1
1
. (8)
Multiplying by a constant does not change the choice
for c*:
′′ =× − () +× JP P cc c TP TN 1. (9)
It can be easily seen that Equation 5 is equal to Equa-
tion 9 when r =( 1-P).
2 Consequently, Youden’s J can
be interpreted as a decision theoretic approach which
uses a cost ratio equal to the proportion of healthy per-
sons in the population (also see, e.g., [9], p. 572, or [10],
p. 8). Thus, if the majority of the target population is
diseased (1 - P = r < 0.5), classification errors with
respect to healthy individuals are valued as more costly;
if prevalence is low (1 - P = r > 0.5), classification errors
with respect to diseased individuals are valued as more
costly. Only when the prevalence is 0.5, does Youden’s J
evaluate classification errors for both groups as equally
costly.
Index J is now contrasted with a comprehensive deci-
sion theoretical approach in which a fixed cost ratio is
used. Additional file 2: Table S2 and Additional file 3:
Table S3 tabulate the fictitious outcomes of a marker or
test under three ordered thresholds (c equals 1, 2, and
3, respectively) for a group of 120 individuals. Addi-
tional file 2: Table S2 has a prevalence of 25%, and
Additional file 3: Table S3 of 75%. Although the tables
are different in the cells of the respective classification
tables, they have identical sensitivity and specificity.
In this example it is assumed that a decision maker
(that is, a given patient, physician, or health care sys-
tem), has determined a fixed cost ratio expressing equal
costs for false positives and false negatives, which comes
down to r = 0.5. Although in practice this cost-ratio
may be open to debate, we assume that it is a valid
representation of the decision maker’s costs and bene-
fits. The last column of Additional file 2: Table S2 and
Additional file 3: Table S3 show the weighted kappa
under this cost ratio. In the 25% prevalence scenario,
(0.5) is highest for c = 3. In the case of a prevalence of
75%, however, as a result of a different compound of
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tables, a different threshold, viz. c = 2, should be chosen.
By contrast, Youden’s J ([1 - P]) gives identical values
in both tables (see fifth column). The difference in com-
pound of correct and incorrect decisions in like tables
does not affect the choice of threshold: c = 2 is chosen
in both. Obviously, different cost ratio’s are used in both
tables. In Additional file 2: Table S2, r =1-P = 0.75,
which denotes that a misclassification of one diseased
person is valued as equally costly as three misclassified
healthy persons. By contrast, in Additional file 3: Table
S3, a cost ratio r =1-P = 0.25 is used, which denotes
that a misclassification of one healthy person is three
times as costly as a misclassified diseased person.
It was shown that when using Youden’si n d e xt o
obtain optimal thresholds, one implicitly uses decision
theory with misclassification costs which depend on the
prevalence of the disease; more specifically, a cost ratio
(costs for the diseased relative to the total costs) which
is equal to one minus the prevalence proportion is
employed. In addition, it was illustrated that in popula-
tions with identical test sensitivity and specificity, but
with different prevalence, the employed cost ratio of J
changes with the prevalence, whereas in a decision the-
ory framework it is fixed. All this showed that, although
it seems as if one can choose to take a decision theoretic
approach (see, e.g., [11], p. 298) or not, the use of a cho-
sen cut-off is invariably optimal with reference to some
fixed cost ratio. Self-evidently, when using the Youden
index, it is doubtful whether this population-dependent
cost ratio actually represents the decision maker’sp r e -
ferences. Likewise, when using the index in populations
with a different prevalence, the cut-off is optimal with
reference to a different cost ratio. This may be undesir-
able, because it is highly unlikely that a decision maker’s
evaluation of classification errors varies from one popu-
lation to another. For example, it is hard to imagine that
an oncologist evaluates false negatives differently for
males (higher prevalence) and females (lower preva-
lence) in testing for lung cancer.
It should be noted that there are settings, such as a
health care system, in which the use of Youden’s J
makes sense. In a low prevalence population a health
care system would typically use a screening test, and in
such situations a desirable test would have high sensitiv-
ity and high predictive value of a negative test, since the
consequence of a positive screening would be no more
than a direction to see a doctor. The threshold with
maximal J = (1 - P), P near zero would be optimal. In
ah i g hp r e v a l e n c ep o p u l a t i o n ,t h eh e a l t hc a r es y s t e m
would prefer a test with high specificity and high predic-
tive value of a positive classification, since a positive
outcome would lead to clinical action such as invasive
procedures. The threshold with maximal J = (1 - P), P
near one would be optimal. This note, therefore, does
not warn against using Youden’s J per se, but against
using it as a ‘by default’ method.
Sometimes, the consequences of incorrect test results
and the disease prevalence may not yet have been deter-
mined, for example, in the early stages of test develop-
ment. One may ask how an optimal cut-off should then
be established. The answer is that in this phase there is
no need for a cut-off yet. Instead, the main aim is to
assess the predictive utility of the test. To that end an
index such as the area under the curve of the receiver
operating curve [9] may be used.
In practice, a precise determination of the costs and
benefits of incorrect and correct classifications may be
rather difficult. In such cases, attention may be
restricted to r, the ratio of relative costs. Fortunately,
the exact cost ratio is not needed in a decision theoretic
framework; all that is needed is a qualitative indication
of which of the two classification errors is more impor-
tant to avoid [12]. For an illustration of determining the
costs of misclassification in testing in psychiatry, see
Smits et al. [7].
Although the Youden index is popular in some clinical
domains, the most popular index for setting thresholds
on medical tests is the odds ratio (see, e.g., [13]).
3 Krae-
mer [6,13] has shown that this index is unsuitable for
this task, however. To illustrate why, the log transforma-
tion of this index is presented: log(odds ratio) = log
(TNc)+l o g ( T P c)-l o g ( F N c)-l o g ( F P c); commonly, the
threshold with the highest log odds ratio is chosen. This
formula shows that the logs of the two correct classifica-
tion proportions get weight 1 and the logs of the two
incorrect classification proportions get weight -1. Conse-
quently, the two correct classifications on the one hand
and two incorrect classifications on the other are
lumped together, and a specific value of the log odds
ratio may be the result of many different compilations
of proportions in the classification table. Thus, the
index tends to indicate whatever is the best quality of a
test; for some tests this is sensitivity, and for other tests
this is specificity [13]. For a decision theoretic approach,
it should be known what quality is being optimized, and
obviously the odds ratio does not provide this
information.
Instead of automatically using Youden’si n d e xo rt h e
odds ratio, test developers should explicitly make use of
decision theory for setting thresholds. To that end an
abundant literature on setting genuinely optimal cut-
offs, such as the book by Kraemer [6], is available.
Summary
Youden’s index, the sum of sensitivity and specificity
minus one, is a method for obtaining thresholds on
medical tests. It implicitly employs a ratio of
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prevalence proportion. It is doubtful whether this cost
ratio represents the decision maker’s true preferences in
all cases. In addition, from a decision theoretic point of
view, the obtained threshold is optimal with reference to
a variable cost ratio; when the test is used a in different
population, the chosen threshold may be optimal with
reference to a different cost ratio. It is argued that
instead of using the index by default, researchers should
explicate their cost ratio in a decision theoretic frame-
work to obtain genuinely optimal thresholds.
Appendix
1Maximizing Equations 2 and 4 is equivalent to finding
that particular cut-off point of the receiver operating
characteristic curve where its slope equals (1 - P ) × (1 -
r)/(P × r) (e.g., [14], Eq. 1).
2It can also be shown that when using this cost ratio, J
and (r) give identical results (also see, [13], Table II).
Noting that TPc=S E c × P,T N c =S P c ×( 1-P), FNc =( 1-
SEc)×( 1-P), and FPc =( 1-SP)×P , the numerator of
Equation 6 can be written as P ×( 1-P )×S E c ×S P c -( 1-
SEc)×( 1-S P c)=P ×( 1-P)×( S P c +S E c -1 ) .T h e
denominator can be rewritten as r × P + Qc ×( 1-r - P).
This leads to the following equation, (r)c = P ×( 1-P )×
(SPc +S E c -1 ) /(r × P + Qc ×[ 1-r - P]). It can be easily
seen that Equation 6 reduces to Equation 1 when r =1-P.
3W a r r e n s[ 1 5 ]s h o w e dt h a tt h eo d d sr a t i oc a nb e
transformed into a weighted kappa. These two indices
do not necessarily lead to identical choices for c,
however.
Additional material
Additional file 1: Table 1 - Decision table for testing situation. This is
the decision table with some squares and some definitions in the
middle.
Additional file 2: Table 2 - Situation 1, prevalence is 25%.T h i s
contains several two by two tables in a large table, the entries in the first
small table are 36, 54, 6, and 24.
Additional file 3: Table 3 - Situation 2, prevalence is 75%.T h i s
contains several two by two tables in another large table, the entries in
the first small table are 12, 18, 18, and 72.
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